N/A
Completed N=49
Treatment of Androgenetic Alopecia in Males
androgenetic alopecia · Hair Loss · Male Pattern Baldness
Source: ClinicalTrials.gov NCT00947505 ↗
Enrolled (actual)
49
Serious AEs
0.0%
Results posted
Jul 2012
Primary outcomePrimary: Changes in Terminal Hair Count at 16 and 26 Weeks Over Baseline — 17.7; 2.8; 18.4; 1.6 change in terminal hair count
Summary
The purpose of this study is to evaluate the efficacy of the HairMax LaserComb 2009 7 Beam model in promoting hair growth in males diagnosed with androgenetic alopecia when treatment is applied as directed.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Changes in Terminal Hair Count at 16 and 26 Weeks Over Baseline |
17.7; 2.8; 18.4; 1.6 | — |
Eligibility Criteria
Inclusion Criteria
- Diagnosis of androgenetic alopecia
- Fitzpatrick Skin Types I-IV
- Norwood-Hamilton IIa to V
- Active hair loss within last 12 months
Exclusion Criteria
- Photosensitivity to laser light
- Malignancy in the target area
Data sourced from ClinicalTrials.gov (NCT00947505). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.